Training in Emerging Infectious Diseases

描述(由申请人提供)：此申请是我们在宾夕法尼亚大学的新兴传染病(EID)培训计划的第二次竞争性续签，该培训计划每年支持3名博士后和2名博士后学员。在70多名主要隶属于微生物学项目的教员中，有12名教员是这一开斋节T32的培训员。所有的培训者都有重要的EID研究计划，其中7人得到了中大西洋地区生物防御和新发传染病卓越中心的资助。一个活跃的执行委员会和一个经验丰富的内部咨询委员会确保了该计划对新出现和重新出现的病原体的研究保持非常密切的关注。因此，当其他人加入开斋节计划时，他们的开斋节计划就会被从计划中删除。该计划将开斋节研究培训与我们的培训人员结合起来，开设了广受欢迎的开斋节讲座课程、严格的BSL3培训计划和公共卫生证书计划。我们最近推出了针对学生和博士后的个人发展计划，这使得我们能够根据学员的需求量身定做我们的培训活动。重要的是，宾夕法尼亚州立大学继续为培训活动提供重要的直接支持，包括为我们新的ABSL3/BSL3提供700万美元，并通过支持博士前实习生进入研究生院的头21个月。因此，我们的T32只有在学员完成所有课程作业和初试后才能为他们提供支持。到目前为止，这个T32已经支持了28名实习生，几乎每个人都有两年的时间，包括13名博士生，4名博士/博士生，1名VMD/博士生和10名博士后研究员。我们的28名学员在15个不同培训师的实验室工作过。只有一位新近加入的培训师没有此T32计划支持的学员。在28名现任和过去的受训人员中，15名是女性，13名是男性，4名是少数群体/弱势群体(14%)。我们的留校率为93%，那些完成培训并离开宾夕法尼亚大学的人已经获得了顶尖机构的好职位(博士后)和优秀的博士后职位，其中大多数人继续研究新兴传染病病原体。我们的实习生取得的成就，加上他们离开宾夕法尼亚大学以来的职业进步，表明我们的T32项目确实在培养有前途的年轻科学家，使他们能够进入新兴传染病领域的职业生涯。

DESCRIPTION (provided by applicant): This application represents the second competing renewal for our Training in Emerging Infectious Disease (EID) Training program based at the University of Pennsylvania that supports 3 predoctoral and 2 postdoctoral trainees per year. Of the more than 70 faculty whose primary affiliation is with the microbiology program, a select group of 12 faculty are trainers with this EID T32. All of the trainers have significant EID research programs, and 7 have been funded by the Middle Atlantic Regional Center of Excellence in Biodefense and Emerging Infectious Diseases. An active Executive Committee coupled with an experienced Internal Advisory Committee insures that this program retains a very tight focus on the study of emerging and re-emerging pathogens. As a result, trainers have been dropped from the program when their EID programs have faded while others have been added. This program has served to coalesce EID research training on our campus, with our trainers instituting a popular EID lecture course, a rigorous BSL3 training program, and a Certificate in Public Health Program. Our recent introduction of Individual Development Plans for our students and postdocs is making it possible for us to tailor our training activities to bes meet the needs of our trainees. Importantly, Penn continues to provide significant, direct support to training activities, including $7 million for our new ABSL3/BSL3 and via supporting predoctoral trainees for their first 21 months of graduate school. Thus, our T32 supports trainees only after they have completed all coursework and their prelim exams. Thus far, this T32 has supported 28 trainees, almost all for 2 years each, including 13 Ph.D. students, 4 M.D./Ph.D. students, 1 VMD/Ph.D. student and 10 Ph.D. postdoctoral fellows. Our 28 trainees have worked in the labs of 15 different trainers. Only one very recently added trainer has not had a trainee supported by this T32 program. Of the 28 current and past trainees, 15 are women, 13 are men, and 4 are minorities/disadvantaged (14%). Our retention rate is 93%, and those who have completed training and left Penn have obtained good positions (for the postdocs) and excellent postdoctoral positions at leading institutions, with most continuing to study emerging infectious agents. The accomplishments of our trainees coupled with their career progress since leaving Penn shows that our T32 program is indeed training promising young scientists to enter careers in Emerging Infectious Diseases.